Estimating the Number of Antiretroviral Treatment Facilities Based on the Wilson–Blower Method

Ntambwe Malangu The implementation of the comprehensive plan for the care, management, and treatment of HIV and AIDS in South Africa [1] needs to be supported by all. It is encouraging to note that Wilson and Blower [2] used South Africa to develop a novel method to determine the optimal strategy for allocating antiretroviral treatment (ART) sites among healthcare facilities (HCFs) in KwaZulu–Natal. An equitable allocation of HCFs is necessary to ensure that each individual with HIV will have an equal chance of receiving antiretroviral drugs (ARVs). We have applied their method to determine the number of ART HCFs per district in KwaZulu–Natal. We fi rst set out to assemble basic details about the KwaZulu–Natal health districts, namely, population and number of hospitals and fi xed and mobile clinics. Secondly, by using population data as reported in the KwaZulu– Natal Department of Health 2004 annual report [3], and based on a 10% HIV prevalence, we determined the HIV population per district and also as a percentage of the total HIV population in the province. Finally, we calculated the number of ART HCFs, based on the premise that 54 ART HCFs will serve 100% of the HIV population in the province. By contrasting the estimated number of ART HCFs with the current ART HCFs, we calculated the number of ART HCFs that still need to be established. The national target for access to HCFs is 10,000 habitants per one fi xed primary health-care (PHC) facility [2]. A PHC facility could be a clinic, a community health center, or a hospital. At present, there is one fi xed PHC facility for 17,215 inhabitants in KwaZulu–Natal [3]. With regard to ART, the 54 HCFs proposed by Wilson and Blower translate to 18,076 people with HIV per facility (Table 1). This number is close to the actual fi gure of 17,215 inhabitants per facility in the province. In terms of equity, it could be argued, for instance, that the two facilities in the eThekwini district cannot be expected to provide ARVs to the estimated 319,994 individuals with HIV. In comparison, the Umziyathi, Amajuba, Umkhanyakude, Uthungulu, and Ugu districts currently have the same number of ART HCFs as eThekwini, but serve smaller populations (Table 1). This refl ects the fact that the choice of the current facilities was guided more by practical considerations, such as availability of staff and infrastructure, than by the principle of equity as suggested by the World Health Organization [4]. From our calculations, it seems that in order to achieve treatment equity for individuals with HIV in KwaZulu–Natal, more ARV HCFs should be established as follows: 15 in eThekwini, four each in Umgungundlovu and Zululand, three each in Uthukela and Uthungulu, two each in Ugu and iLembe, and one each in Amajuba, Sisonke, Umzinyathi, and Umkhanyakude. As a recommendation, future rollout of ART should take into consideration the principle of equity. This will ensure that all people with HIV have equal access to ARVs from their nearest HCF. We show that by applying the Wilson–Blower method, it is possible to determine the number of health-care facilities where ARVs would be equitably provided. This correspondence letter was peer reviewed.

[1]  P. McGrath Future Scenarios for Academic Medicine Should Include Other Health Disciplines , 2005, PLoS Medicine.

[2]  Richard Smith,et al.  Five Futures for Academic Medicine , 2005, BMJ : British Medical Journal.

[3]  Some Tolerance for Fur—Animal Studies in PLoS Medicine , 2005, PLoS Medicine.

[4]  J. Lenzer,et al.  What Can We Learn from Medical Whistleblowers? , 2005, PLoS medicine.

[5]  V. Barbour,et al.  Why PLoS Sponsored a Roundtable of Medical Whistleblowers , 2005, PLoS medicine.

[6]  Mike Clarke,et al.  Is Evidence-Based Medicine Relevant to the Developing World? , 2005, Evidence-based complementary and alternative medicine : eCAM.

[7]  Douglas K. Martin,et al.  Nanotechnology and the Developing World , 2005, PLoS medicine.

[8]  David P. Wilson,et al.  Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries , 2005, PLoS medicine.

[9]  Adam Briggle,et al.  Living with the Genie: Essays on Technology and the Quest for Human Mastery , 2005 .

[10]  Peter Andras,et al.  The future of 'pure' medical science: the need for a new specialist professional research system. , 2005, Medical hypotheses.

[11]  P. András,et al.  Medical research funding may have over-expanded and be due for collapse. , 2005, QJM : monthly journal of the Association of Physicians.

[12]  B. Charlton,et al.  Conflicts of interest in medical science: peer usage, peer review and 'CoI consultancy'. , 2004, Medical hypotheses.

[13]  M. Mccarthy AIDS vaccine fails in Thai trial , 2003, The Lancet.

[14]  Z. Bhutta Practising just medicine in an unjust world , 2003, BMJ : British Medical Journal.

[15]  M. Mccarthy HIV vaccine fails in phase 3 trial , 2003, The Lancet.

[16]  A. Sleigh,et al.  Economics of malaria control in China: Cost, performance and effectiveness of Henan's consolidation programme , 2002 .

[17]  F S Cromwell,et al.  Inaugural editorial. , 1984, Occupational therapy in health care.